GlassScriptPhysician profile
Michael T Mineo
NPI 1801849385
$26,094.73
in general payments reported to CMS, 2019-2025
71 companies · $7,881 in 2025
The $7,881 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,329 · 2020: $663 · 2021: $838 · 2022: $2,128 · 2023: $3,321 · 2024: $8,935 · 2025: $7,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,380 · Consulting Fee: $5,875 · Long Term Medical Supply Or Device Loan: $5,143 · Travel and Lodging: $706 · Entertainment: $17.39 · Education: $15.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,380.42 |
| Consulting Fee | $5,875.00 |
| Long Term Medical Supply Or Device Loan | $5,142.85 |
| Travel and Lodging | $706.12 |
| Entertainment | $17.39 |
| Education | $15.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $7,085.24 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Hmu Consumables, LLC | $5,142.85 | 2025 | Dornier Medtech |
| Astellas Pharma US INC | $976.09 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Pfizer INC. | $971.61 | 2019-2025 | |
| Janssen Biotech, INC. | $935.03 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $837.13 | 2019-2025 | |
| Boston Scientific Corporation | $706.81 | 2019-2025 | Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $675.65 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $592.48 | 2019-2025 | Provenge |
| Convatec INC. | $581.96 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $539.49 | 2019-2023 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $510.98 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $434.53 | 2019-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $434.02 | 2021-2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $428.77 | 2019-2025 |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $409.37 | 2022-2025 | Pylarify |
| Urogen Pharma, INC. | $400.39 | 2021-2024 | Jelmyto |
| Edap Technomed INC | $298.97 | 2022-2025 | |
| Medtronic, INC. | $297.66 | 2023-2025 | Interstim |
| Tolmar, INC. | $215.59 | 2023-2025 | Jatenzo, Eligard |
| Blue Earth Diagnostics | $192.61 | 2021-2025 | Posluma |
| Medtronic USA, INC. | $190.70 | 2019 | |
| Coloplast Corp | $180.61 | 2019-2022 | |
| Urovant Sciences INC | $152.48 | 2022 | |
| Aytu Biopharma, INC. | $151.03 | 2019 | |
| Tempus Ai, INC | $147.73 | 2024-2025 | Xt Cdx |
| Baxter Healthcare | $132.66 | 2023 | Tisseel |
| Allergan, INC. | $130.13 | 2019-2022 | |
| Neotract INC. | $125.14 | 2019 | |
| Ambu INC. | $119.27 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $117.96 | 2019-2022 | |
| Ethicon US, LLC | $116.58 | 2023 | Echelon Flex |
| Astrazeneca Pharmaceuticals LP | $105.27 | 2020-2021 | |
| Endo USA, INC. | $104.32 | 2024-2025 | Aveed, Xiaflex |
| Axogen | $99.40 | 2025 | |
| Novartis Pharmaceuticals Corporation | $95.80 | 2024-2025 | |
| Amgen INC. | $91.45 | 2019-2023 | Xgeva |
| Verity Pharmaceuticals INC. | $88.69 | 2025 | Tlando, Trelstar |
| Olympus America INC. | $81.25 | 2024-2025 | Itind System |
| Alnylam Pharmaceuticals INC. | $78.97 | 2021-2022 | |
| Antares Pharma, INC. | $78.23 | 2020-2023 | Tlando, Nocdurna, Xyosted |
| 180 Medical, INC. | $77.21 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $76.87 | 2020-2025 | Aptra |
| Axonics, INC. | $73.65 | 2020 | |
| Hollister Incorporated | $65.33 | 2022-2023 | Onli, Vapro Plus Pocket |
| Telix Pharmaceuticals | $60.23 | 2022-2023 | Illuccix |
| Abc Home Medical Supply, INC. | $58.27 | 2022 | |
| Immunitybio, INC. | $51.37 | 2024-2025 | |
| Healthtronics Stone Solutions, LLC | $48.54 | 2024 | Dornier Medtech |
| Laborie Medical Technologies Corp. | $48.43 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $44.24 | 2022-2023 | |
| Photocure INC | $41.88 | 2019 | |
| Myovant Sciences INC. | $35.93 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $29.85 | 2025 | |
| Teleflex LLC | $27.42 | 2024 | Urolift |
| Acerus Pharmaceuticals Corporation | $27.39 | 2020-2021 | |
| Glaxosmithkline, LLC. | $24.43 | 2023 | Trelegy Ellipta |
| Travere Therapeutics, INC. | $23.53 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $23.20 | 2019 | |
| Genzyme Corporation | $22.84 | 2022 | |
| Valencia Technologies Corporation | $22.31 | 2025 | Ecoin Device Kit |
| Amag Pharmaceuticals, INC. | $22.11 | 2019 | |
| Metuchen Pharmaceuticals | $21.65 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.70 | 2022 | |
| Baudax Bio INC. | $17.52 | 2020 | |
| Therapeuticsmd, INC. | $17.44 | 2019 | |
| Provepharm INC. | $17.39 | 2024 | Bludigo |
| Innovation Technologies INC | $14.59 | 2025 | Irrisept |
| Halozyme INC | $13.56 | 2023 | |
| Civco Medical Instruments | $12.95 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,814.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mineo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.